Antisense Therapeutics Limited Stock Analysis
| ATHJF Stock | USD 0.04 0.00 0.00% |
Antisense Therapeutics Limited is overvalued with Real Value of 0.0376 and Hype Value of 0.04. The main objective of Antisense Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Antisense Therapeutics Limited is worth, separate from its market price. There are two main types of Antisense Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Antisense Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Antisense Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Antisense |
Antisense Pink Sheet Analysis Notes
About 19.0% of the company shares are held by company insiders. The book value of Antisense Therapeutics was presently reported as 0.03. The company recorded a loss per share of 0.01. Antisense Therapeutics had not issued any dividends in recent years. The entity had 50:49 split on the 10th of April 2018. Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Antisense Therapeutics Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Antisense Therapeutics Limited please contact the company at 61 3 9827 8999 or go to https://www.antisense.com.au.Antisense Therapeutics Investment Alerts
| Antisense Therapeutics is way too risky over 90 days horizon | |
| Antisense Therapeutics has some characteristics of a very speculative penny stock | |
| Antisense Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.78 M. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 1.71 M. | |
| Antisense Therapeutics Limited has accumulated about 19.23 M in cash with (7.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 19.0% of the company shares are held by company insiders |
Antisense Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Antisense Therapeutics's market, we take the total number of its shares issued and multiply it by Antisense Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Antisense Therapeutics shows the Mean Deviation of 9.72, risk adjusted performance of 0.0993, and Standard Deviation of 39.12. Antisense Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Antisense Therapeutics standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if Antisense Therapeutics is priced correctly, providing market reflects its regular price of 0.042 per share. As Antisense Therapeutics appears to be a penny stock we also recommend to validate its information ratio numbers.Antisense Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Antisense Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Antisense Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Antisense Therapeutics Predictive Daily Indicators
Antisense Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Antisense Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Antisense Therapeutics Forecast Models
Antisense Therapeutics' time-series forecasting models are one of many Antisense Therapeutics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Antisense Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Antisense Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Antisense Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Antisense shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Antisense Therapeutics. By using and applying Antisense Pink Sheet analysis, traders can create a robust methodology for identifying Antisense entry and exit points for their positions.
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Antisense Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Complementary Tools for Antisense Pink Sheet analysis
When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |